Toripalimab Plus FLOT in Locally Advanced Gastric Cancer

Clinical trial NCT04891016 · RECRUITING

Trial details

NCT number: NCT04891016
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy Immune Checkpoint Inhibitor Locally Advanced Gastric Carcinoma

Start date: 2021-06-25
Primary completion: 2025-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.